Results 181 to 190 of about 1,686,494 (285)

Implementation of an electronic registry to monitor quality of care for febrile episodes in pediatric patients with cancer in Central America and the Caribbean. [PDF]

Support Care Cancer
Levy J, Estripeaut D, Muniz-Talavera H, Chen Y, Bhakta N, Cojulun AC, Badilla KC, Caniza MA, Gonzalez JCC, Rodriquez DJD, Rosalez MAG, Homsi MR, Torres MTL, Melgar M, Vazquez M, Wardell JR, Devidas M, Licona S, Mukkada S.   +18 more
europepmc   +1 more source

Recurring Fever [PDF]

Deutsches Ärzteblatt international, 2019
Vincent, Casteleyn, Jakob, Höppner
openaire   +2 more sources

Prediction of Relapse and Glucocorticoid Dependence in Eosinophilic Granulomatosis With Polyangiitis: Findings From a Large European Cohort

Arthritis &Rheumatology, EarlyView.
Objective Eosinophilic granulomatosis with polyangiitis (EGPA) is a small vessel vasculitis characterized by eosinophilia, asthma, and ear, nose, and throat (ENT) involvement. Although glucocorticoids (GCs) are effective in controlling symptoms, relapses and GC dependence are common. The aim of this study was to develop predictive models for vasculitis
Matthias Papo, Pauline Martinot, Renato A. Sinico, Vítor Silvestre‐Teixeira, Nils Venhoff, Maria‐Letizia Urban, Michele Iudici, Juliane Mahrhold, Francesco Locatelli, Giulia Cassone, Franco Schiavon, Benjamin Seeliger, Thomas Neumann, Claudia Feder, Matthieu Groh, Chiara Marvisi, Maxime Samson, Thomas Barba, David Jayne, Arianna Troilo, Jens Thiel, Bernhard Hellmich, Sara Monti, Carlomaurizio Montecucco, Carlo Salvarani, Jean‐Emmanuel Kahn, Bernard Bonnotte, Cécile‐Audrey Durel, Xavier Puéchal, Luc Mouthon, Loïc Guillevin, Giacomo Emmi, Augusto Vaglio, Raphaël Porcher, Benjamin Terrier, on behalf of the French Vasculitis Study Group and the Eosinophilic Granulomatosis with Polyangiitis European Study Group   +35 more
wiley   +1 more source

Right Atrial Myxoma Presenting as Fever of Unknown Origin: A Rare Case Report. [PDF]

Clin Case Rep
Basnet A, Maskey A, Koirala P, Joshi S, Mainali G.   +4 more
europepmc   +1 more source

PRIMARY FEVER

AJN, American Journal of Nursing, 1988
openaire   +3 more sources

A multifaceted interplay between hemophagocytosis, IL‐18 and type I IFN distinguishes Still disease from other autoinflammatory diseases

Arthritis &Rheumatology, Accepted Article.
Objectives The unknown pathophysiology and the lack of specific features for systemic Juvenile Idiopathic arthritis and adult‐onset Still disease (collectively Still disease/SD) delays diagnosis and appropriate treatment. The goal of this study was to identify features and mechanisms that distinguish SD from other systemic autoinflammatory diseases ...
Yvonne M. Mueller, Charlotte Girard, Harmen J. G. van de Werken, Stefan J. Erkeland, Dwin G.B. Grashof, Laurie Vaillant, Renske J.H. den Dekker, Iris van Zuijen, Sharon Veenbergen, Fanny Coffin, Eric Bindels, Yvan Jamilloux, Katerina Laskari, ImmunAID consortium, Vassili Soumelis, Bruno Fautrel, Cem Gabay, Peter D. Katsikis   +17 more
wiley   +1 more source

Querying Q fever: spatiotemporal patterns and environmental drivers in French Guiana. [PDF]

BMJ Glob Health
Desmoulin A, Esparon A, Quet F, Teillet C, Thill P, Nacher M, Roux E, Catry T, Epelboin L.   +8 more
europepmc   +1 more source

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

British Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić, Elvira Meni Maria Gkrinia, Patrick Eustaquio, Andrea Katrin Faour, Dinko Vitezić   +4 more
wiley   +1 more source

Risk of Yellow fever outbreak in a rural community: Assessment of knowledge, attitude and prevalence of risk factors in Nigeria

International Journal of Infectious Diseases, 2020
E. Tobin, G. Odigie, J. Gbakeji, M. Okonofua, N. Akpede, C. Nnadi   +5 more
doaj   +1 more source

Genetic variability and phylogenetic analysis of the VP2 gene of feline parvovirus in Harbin. [PDF]

Front Vet Sci
Luan Q, Weng C, Guo Y, Yang P, Wu G, Ding G, Li Y.   +6 more
europepmc   +1 more source